630421-73-7 Usage
General Description
1,6-Dichloro-isoquinoline is a chemical compound with the formula C9H6Cl2N. It is a white to pale yellow solid with a melting point of 62-64°C and a boiling point of 303-305°C. 1,6-DICHLORO-ISOQUINOLINE is used in the synthesis of various pharmaceuticals and agrochemicals, as well as in the manufacture of dyes and other organic compounds. It is also used as an intermediate in the production of other chemicals. 1,6-Dichloro-isoquinoline is classified as a hazardous substance, with potential health effects including irritation of the skin, eyes, and respiratory system, and is toxic if swallowed or inhaled. It is important to handle and use this chemical with caution and in accordance with proper safety procedures.
Check Digit Verification of cas no
The CAS Registry Mumber 630421-73-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,0,4,2 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 630421-73:
(8*6)+(7*3)+(6*0)+(5*4)+(4*2)+(3*1)+(2*7)+(1*3)=117
117 % 10 = 7
So 630421-73-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H5Cl2N/c10-7-1-2-8-6(5-7)3-4-12-9(8)11/h1-5H
630421-73-7Relevant articles and documents
COMBINATION THERAPIES FOR TREATMENT OF CANCER
-
Page/Page column 295; 296, (2016/04/09)
Combination therapies for treatment of cancers associated with mutations in the KRAS gene are provided. Compositions comprising therapeutic agents for treatment of cancers associated with mutations in the KRAS gene are also provided.
COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS
-
Page/Page column 133, (2008/06/13)
The present invention relates to compounds useful as Chemokine Receptor antagonists. Compounds of general formula (I) are provided or pharmaceutically acceptable salts thereof. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and compositions for the inhibition of Chemokine Receptors and also for the treatment of various diseases, conditions, or disorders, including acute or chronic inflammatory disease, cancer, and osteolytic bone disorders.
